13-valent pneumococcal conjugate vaccine use in children 6 through 18 years of age with immunocompromising conditions : GRADE of evidence
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i


13-valent pneumococcal conjugate vaccine use in children 6 through 18 years of age with immunocompromising conditions : GRADE of evidence

Filetype[PDF-294.89 KB]


  • English

  • Details:

    Supporting Files

    • No Additional Files

    More +

    Related Documents

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov